These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8439602)

  • 1. Disruption of sensory gating by the alpha 2 selective noradrenergic antagonist yohimbine.
    Stevens KE; Meltzer J; Rose GM
    Biol Psychiatry; 1993 Jan; 33(2):130-2. PubMed ID: 8439602
    [No Abstract]   [Full Text] [Related]  

  • 2. Yohimbine impairs P50 auditory sensory gating in normal subjects.
    Adler LE; Hoffer L; Nagamoto HT; Waldo MC; Kisley MA; Giffith JM
    Neuropsychopharmacology; 1994 Jul; 10(4):249-57. PubMed ID: 7945735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential.
    Keedy SK; Marlow-O'Connor M; Beenken B; Dorflinger J; Abel M; Erwin RJ
    Psychopharmacology (Berl); 2007 Jan; 190(1):117-25. PubMed ID: 17096083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory gating revisited: relation between brain oscillations and auditory evoked potentials in schizophrenia.
    Brockhaus-Dumke A; Mueller R; Faigle U; Klosterkoetter J
    Schizophr Res; 2008 Feb; 99(1-3):238-49. PubMed ID: 18160261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noradrenergic modulation in the olfactory bulb influences spontaneous and reward-motivated discrimination, but not the formation of habituation memory.
    Mandairon N; Peace S; Karnow A; Kim J; Ennis M; Linster C
    Eur J Neurosci; 2008 Mar; 27(5):1210-9. PubMed ID: 18364038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating.
    Stevens KE; Fuller LL; Rose GM
    Brain Res; 1991 Jul; 555(1):91-8. PubMed ID: 1681997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical modulation of the P13 midlatency auditory evoked potential in the rat.
    Miyazato H; Skinner RD; Garcia-Rill E
    Neuroscience; 1999; 92(3):911-20. PubMed ID: 10426532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory-evoked response of the cortex after yohimbine administration: phase advance effect of central noradrenergic activation.
    Shinba T; Ando Y; Ozawa N; Yamamoto K
    Brain Res Bull; 1992 Mar; 28(3):463-71. PubMed ID: 1591603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated acoustic stimulation of acute schizophrenic patients and the habituation of EEG power changes.
    Schellenberg R; Knorr W; Beyer H; Kropf S; Schindler M; Bölsche F; Kondratjuk G
    Int J Psychophysiol; 1989 Mar; 7(1):55-63. PubMed ID: 2925465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional influence of the central noradrenergic system on the skin conductance activity in rats.
    Yamamoto K; Ozawa N; Shinba T; Hoshino T
    Schizophr Res; 1994 Sep; 13(2):145-50. PubMed ID: 7986771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings.
    Waldo MC; Cawthra E; Adler LE; Dubester S; Staunton M; Nagamoto H; Baker N; Madison A; Simon J; Scherzinger A
    Schizophr Res; 1994 May; 12(2):93-106. PubMed ID: 8043530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gating and habituation deficits in the schizophrenia disorders.
    Braff DL; Swerdlow NR; Geyer MA
    Clin Neurosci; 1995; 3(2):131-9. PubMed ID: 7583619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.
    Powell SB; Palomo J; Carasso BS; Bakshi VP; Geyer MA
    Psychopharmacology (Berl); 2005 Jul; 180(3):491-500. PubMed ID: 15719216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia.
    Potter D; Summerfelt A; Gold J; Buchanan RW
    Schizophr Bull; 2006 Oct; 32(4):692-700. PubMed ID: 16469942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia.
    Griffith JM; O'Neill JE; Petty F; Garver D; Young D; Freedman R
    Biol Psychiatry; 1998 Jul; 44(2):98-106. PubMed ID: 9646891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic influence on capsaicin-evoked enhancement of dorsal root reflexes in rats.
    Wang J; Ren Y; Zou X; Fang L; Willis WD; Lin Q
    J Neurophysiol; 2004 Oct; 92(4):2017-26. PubMed ID: 15163667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential blockade of presynaptic alpha-adrenoceptors by yohimbine.
    Starke K; Borowski E; Endo T
    Eur J Pharmacol; 1975 Dec; 34(2):385-8. PubMed ID: 186273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobiological studies of sensory gating in schizophrenia.
    Freedman R; Adler LE; Gerhardt GA; Waldo M; Baker N; Rose GM; Drebing C; Nagamoto H; Bickford-Wimer P; Franks R
    Schizophr Bull; 1987; 13(4):669-78. PubMed ID: 2894074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone potentiation of novelty-induced hypoalgesia: characterization of the alpha-noradrenergic receptor subtype.
    Rochford J; Dawes P; Stewart J
    Pharmacol Biochem Behav; 1993 Feb; 44(2):381-6. PubMed ID: 8383341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of early maternal deprivation on auditory information processing in adult Wistar rats.
    Ellenbroek BA; de Bruin NM; van Den Kroonenburg PT; van Luijtelaar EL; Cools AR
    Biol Psychiatry; 2004 Apr; 55(7):701-7. PubMed ID: 15038998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.